captopril has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hattori, T; Kase, Y; Koseki, J; Sadakane, C; Takeda, S | 1 |
2 other study(ies) available for captopril and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Saireito probably prevents mesangial cell proliferation in HIGA mice via PDGF-BB tyrosine kinase inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Becaplermin; Captopril; Cell Proliferation; Cell Survival; Cells, Cultured; Chalcones; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Flavonoids; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Mesangial Cells; Mice; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Receptors, Platelet-Derived Growth Factor; Up-Regulation | 2007 |